|
Volumn 146, Issue 5, 2002, Pages 673-679
|
Pharmacokinetics of a new transdermal testosterone gel in gonadotrophin-suppressed normal men
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANDROSTANOLONE;
ESTRADIOL;
FOLLITROPIN;
GONADOTROPIN;
LUTEINIZING HORMONE;
NORETHISTERONE ENANTATE;
TESTOSTERONE;
ADULT;
AREA UNDER THE CURVE;
ARTICLE;
CLINICAL TRIAL;
COMMON COLD;
CONCENTRATION RESPONSE;
CONTAMINATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG ABSORPTION;
DRUG FORMULATION;
DRUG TOLERABILITY;
GEL;
GONADOTROPIN RELEASE;
HORMONE SUBSTITUTION;
HUMAN;
HUMAN EXPERIMENT;
INJECTION PAIN;
MALE;
NORMAL HUMAN;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RISK ASSESSMENT;
SEXUAL DYSFUNCTION;
TESTOSTERONE BLOOD LEVEL;
TESTOSTERONE RELEASE;
VERTIGO;
VOLUNTEER;
|
EID: 0036099106
PISSN: 08044643
EISSN: None
Source Type: Journal
DOI: 10.1530/eje.0.1460673 Document Type: Article |
Times cited : (34)
|
References (20)
|